ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Orthopaedics and sports medicine · Bone Joint J · 2026-08-01

Meta-analysis of 10 matched cohort studies (96,356 patients) found GLP-1 receptor agonist use before hip or knee replacement was associated with fewer 90-day surgical complications (pooled RR 0.73); evidence certainty was very low, and in knees only readmissions fell.

Meta-analysisn = 96,356
Rudran et al. Glucagon-like peptide-1 receptor agonists are associated with improved 90-day outcomes after total hip and knee arthroplasty : a systematic review and meta-analysis
Women's health · Am J Obstet Gynecol · 2026-04-28

Systematic review of 22 studies (10 meta-analysed), 49,395 pregnancies with periconceptional GLP-1 RA exposure: no significant association with major malformations, preterm delivery or pregnancy loss; renal malformations OR 1.23, largely driven by one cohort.

Meta-analysisn = 49,395 pregnancies
Hakim et al. Neonatal and obstetric outcomes following periconceptional exposure to glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.